Form S-1 - General form for registration of securities under the Securities Act of 1933:
SEC Accession No. 0001193125-25-226825
Filing Date
2025-10-01
Accepted
2025-10-01 16:30:39
Documents
17

Document Format Files

Seq Description Document Type Size
1 S-1 apvo-20251001.htm S-1 1082783
2 EX-5.1 apvo-ex5_1.htm EX-5.1 29014
3 EX-23.1 apvo-ex23_1.htm EX-23.1 5109
4 EX-FILING FEES apvo_exfilingfees.htm   iXBRL EX-FILING FEES 79675
5 GRAPHIC img57496738_0.jpg GRAPHIC 12962
6 GRAPHIC img136434150_0.jpg GRAPHIC 6733
7 GRAPHIC img136434150_1.jpg GRAPHIC 14823
  Complete submission text file 0001193125-25-226825.txt   1386359

Data Files

Seq Description Document Type Size
19 EXTRACTED XBRL INSTANCE DOCUMENT apvo_exfilingfees_htm.xml XML 14507
Mailing Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121
Business Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121 206-838-0500
Aptevo Therapeutics Inc. (Filer) CIK: 0001671584 (see all company filings)

EIN.: 811567056 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1 | Act: 33 | File No.: 333-290663 | Film No.: 251365035
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)